GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (OTCPK:CVALF) » Definitions » Cyclically Adjusted Price-to-FCF

Covalon Technologies (Covalon Technologies) Cyclically Adjusted Price-to-FCF : (As of May. 22, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Covalon Technologies Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Covalon Technologies Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Covalon Technologies's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Cyclically Adjusted Price-to-FCF Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Covalon Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Covalon Technologies's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Covalon Technologies's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's Cyclically Adjusted Price-to-FCF falls into.



Covalon Technologies Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Covalon Technologies's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Covalon Technologies's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/125.0724*125.0724
=0.000

Current CPI (Dec. 2023) = 125.0724.

Covalon Technologies Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -0.026 98.604 -0.033
201406 0.009 99.473 0.011
201409 -0.059 99.394 -0.074
201412 0.001 98.367 0.001
201503 -0.060 99.789 -0.075
201506 0.018 100.500 0.022
201509 -0.167 100.421 -0.208
201512 -0.031 99.947 -0.039
201603 -0.068 101.054 -0.084
201606 0.012 102.002 0.015
201609 -0.007 101.765 -0.009
201612 -0.017 101.449 -0.021
201703 -0.023 102.634 -0.028
201706 -0.027 103.029 -0.033
201709 0.082 103.345 0.099
201712 -0.007 103.345 -0.008
201803 -0.085 105.004 -0.101
201806 -0.008 105.557 -0.009
201809 0.048 105.636 0.057
201812 -0.132 105.399 -0.157
201903 -0.026 106.979 -0.030
201906 -0.016 107.690 -0.019
201909 0.035 107.611 0.041
201912 -0.138 107.769 -0.160
202003 -0.003 107.927 -0.003
202006 0.015 108.401 0.017
202009 -0.056 108.164 -0.065
202012 -0.023 108.559 -0.026
202103 -0.003 110.298 -0.003
202106 -0.024 111.720 -0.027
202109 0.062 112.905 0.069
202112 0.013 113.774 0.014
202203 -0.096 117.646 -0.102
202206 -0.142 120.806 -0.147
202209 -0.054 120.648 -0.056
202212 -0.020 120.964 -0.021
202303 -0.070 122.702 -0.071
202306 -0.033 124.203 -0.033
202309 -0.010 125.230 -0.010
202312 0.000 125.072 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Covalon Technologies  (OTCPK:CVALF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Covalon Technologies Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies (Covalon Technologies) Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.